Advent Therapeutics Overview
- Founded
-
2014
- Status
-
Private
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$252K
- Investors
-
3
Advent Therapeutics General Information
Description
Developer of legacy drugs designed to address serious unmet medical needs in the underserved neonatal and pediatric patient populations. The company's drugs are prenatal, neonatal and pediatric drugs for orphans to cure disorders in newborn infants in the intensive care unit (ICU), enabling pediatricians and healthcare professionals to care for the fragile in an advanced manner.
Contact Information
Website
www.advent-therapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 6500 Old Carversville Road
- Lumberville, PA 18933-9729
- United States
Advent Therapeutics Timeline
Advent Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Grant | 15-Aug-2020 | $252K | 00000 | Completed | Generating Revenue | |
| 4. Grant | 01-Jan-2020 | 00.000 | 00000 | Completed | Generating Revenue | |
| 3. Early Stage VC | 12-Sep-2016 | 00000 | 00000 | Completed | Startup | |
| 2. Seed Round | 19-Aug-2015 | $120K | $120K | Completed | Startup | |
| 1. Seed Round | 11-Dec-2014 | Completed | Startup |
Advent Therapeutics Patents
Advent Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3170810-A1 | Compositions of vitamin a palmitate, processes for their preparation, uses and methods comprising them | Pending | 11-Feb-2020 | 000000000 | |
| AU-2021220126-A1 | Compositions of vitamin a palmitate, processes for their preparation, uses and methods comprising them | Pending | 11-Feb-2020 |
Advent Therapeutics Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Thomas Hofmann Ph.D | Chief Scientific Advisor | ||
| David Lopez ESQ | Co-Founder, Chief Executive Officer, Chief Financial Officer, Chief Business Officer & President |
Advent Therapeutics Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Eric Floyd Ph.D | Self | Board Member | 000 0000 |
Advent Therapeutics Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| National Institutes of Health | Government | 000 0000 | 000000 0 | ||
| U.S. Department of Health and Human Services | Government | 000 0000 | 000000 0 | ||
| Ben Franklin Technology Partner of Southeastern Pennsylvania | Venture Capital | Minority | 000 0000 | 000000 0 |